Volume 21: Issue 3 (Aug 2022): Transplantation

in Nephrology Self-Assessment Program
Guest Editors: Sumit Mohan MD, MPH and S. Ali Husain, MD, MPH, FASN
Editorial Director: Alice M. Sheridan, MD
Deputy Editor: Martina M. McGrath, MBChB, FASN 

 

AMA PRA Category 1 Credits™ Available
For more information regarding CME for this issue, access the CME tab below

CME Credit Termination Date: July 31, 2024 at 11:59 pm ET; (expired)

Looking for the Full Issue PDF Download?
Scroll to the bottom of the page and select "Download the Full Issue"

Learning Objectives

  • To discuss the evaluation of kidney transplant recipients and kidney donors.
  • To describe current trends in kidney transplantation and the use of deceased donor kidneys.
  • To review the recent literature on the care of kidney transplant recipients.
  • To describe the management of kidney transplant rejection.
  • To review contemporary methods of immunological monitoring of kidney transplant recipients.

It is the policy of the American Society of Nephrology (ASN) that all individuals in a position to control the content of ASN's educational activities are expected to disclose all their and their life spouse/partner's financial relationships with “ineligible companies” within the prior 24 months as well as other non-financial interests. (“Ineligible companies” are those whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients.) Participants should note that the use of products outside U.S. Food and Drug Administration (FDA) approved labeling should be considered experimental and are advised to consult current prescribing information for approval indications.

The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in educational activities, but rather to ensure that these activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. In addition, all faculty were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.

ASN requires all individuals in a position to control content for this activity to complete disclosure forms on the ASN website. Responses are listed below.

Disclosures have been reviewed and assessed by ASN. All relationships with ineligible companies have been identified and all relevant financial relationships have been mitigated.

View the full ASN Conflict of Interest and Disclosure Policy: https://www.asn-online.org/education/cme/coi-disclosure.pdf.

EDITORS:

Alice M. Sheridan, MDEmployer(s): Brigham and Women’s Hospital; No additional relevant financial relationship(s) with ineligible companies to disclose.

Martina M. McGrath, MBChB, FASNEmployer(s): Brigham and Women’s Hospital; VA Boston Medical Center; No additional relevant financial relationship(s) with ineligible companies to disclose.

EDITORIAL AUTHOR:

S. Ali Husain, MD, MPH, FASNEmployer(s): Columbia University Medical Center; Honoraria: Nelson family foundation; Patents or Royalties: Fresenius.

Sumit Mohan, MD, MPH, FASNEmployer(s): Columbia University; Consultancy: Angion Biomedica; Advisory or Leadership Roles: Deputy Editor-Kidney International Reports (ISN); Vice Chair-UNOS, Data advisory committee, Member-SRTR Visiting Committee, Member-ASN Quality committee, National Faculty Chair, ETCLC; Other interests or relationships: Research Funding from NIH (NIDDK, NIHMD and NIBIB) and Kidney Transplant Collaborative.

AUTHORS:

Enver Akalin, MD, FASN—Employer(s): Montefiore Medical Center; Consultancy: CareDx and Immucor; Research Funding: Immucor, Caredx, Angion, NIH; Honoraria: CareDx and Immucor; Advisory or Leadership Roles: CareDx and Immucor.

Yorg Al Azzi, MD, FASN—Employer(s): Montefiore Medical Center; No additional relevant financial relationship(s) with ineligible companies to disclose.

Andrew J. Bentall, MBChB, MDEmployer(s): Mayo Clinic; No additional relevant financial relationship(s) with ineligible companies to disclose.

Angelina Edwards, MDEmployer(s): Houston Methodist Hospital Nephrology; No additional relevant financial relationship(s) with ineligible companies to disclose.

Hassan N. Ibrahim, DrMed, MD, FASNEmployer(s): Houston Methodist; Honoraria: Sharp Health Care System, University of Wisconsin; Advisory or Leadership Roles: Exosome Diagnostics.

Ngan N. Lam, MDEmployer(s): University of Calgary; No additional relevant financial relationship(s) with ineligible companies to disclose.

Carmen Lefaucheur, MD, PhDEmployer(s): Paris Transplant Group, Universite De Paris, AP-HP; Consultancy: CSL Behring; Hansa Biopharm.

Krista L. Lentine, MD, PhD, FASNEmployer(s): Saint Louis University; Consultancy: CareDx, Inc.; Ownership Interests: CareDx, Inc.

Luz Liriano-Ward, MDEmployer(s): Montefiero Medical Center; No additional relevant financial relationship(s) with ineligible companies to disclose.

Kevin Louis, MD, PhDEmployer(s): Hôpital Tenon; No additional relevant financial relationship(s) with ineligible companies to disclose.

Alexandre Loupy, MD, PhDEmployer(s): Université Paris Cité; No additional relevant financial relationship(s) with ineligible companies to disclose.

Lisa M. McElroy, MD, MSEmployer(s): Duke University; Consultancy: Osaka pharmaceuticals; Research Funding: National Institute on Minority Health and Health Disparities under Award Number U54MD012530, Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Award; Honoraria: Osaka pharmaceuticals; Advisory or Leadership Roles: editorial board, clinical transplantation and annals of surgery open.

Rajil B. Mehta, MD, FASNEmployer(s): University of Pittsburgh Medical Center; No additional relevant financial relationship(s) with ineligible companies to disclose.

Dinushika Mohottige, MD, MPHEmployer(s): Duke University; Ownership Interests: All non health care; Honoraria: Mt. Sinai Department of Medicine, University of Nebraska Department of Thoracic and Surgical Oncology, OHSU medicine; Advisory or Leadership Roles: NKF Health Equity Committee, NKF Transplant Advisory Committee Member; Other interests or relationships: NKF Health Equity Advisory Committee Member, NKF Transplant Advisory Committee Member, NIH SDOH PHENX Workgroup.

Chethan M. Puttarajappa, MD, MSEmployer(s): University of Pittsburgh Medical Center; No additional relevant financial relationship(s) with ineligible companies to disclose.

Nagaraju Sarabu, MDEmployer(s): University Hospitals; No additional relevant financial relationship(s) with ineligible companies to disclose.

Carrie A. Schinstock, MDEmployer(s): Mayo Clinic; Research Funding: CSL Bering, Sanofi, Veloxis; Honoraria: CSL Bering, Veloxis; Advisory or Leadership Roles: Veloxis.

Puneet Sood, MD, MPHEmployer(s): University of Pittsburgh Medical Center; No additional relevant financial relationship(s) with ineligible companies to disclose.

ASN STAFF:

Suzanne P. Armstrong, MAEmployer(s): American Society of Nephrology; No additional relevant financial relationship(s) with ineligible companies to disclose.

Commercial Support

There is no commercial support for this issue.

The nephSAP editorial team and the KSAP editorial board extend their sincere appreciation to the following reviewers. Their efforts and insights help improve the quality of these postgraduate education offerings. 

nephSAP Review Panel, Volume 21, Number 3, August 2022

  • Farsad Afshinnia, MD, MS, FASN, University of Michigan, United States
  • Gaurav Agarwal, MD, FASN, University of Alabama at Birmingham, United States
  • Gopal Basu, MBBS, MD, FASN, Alfred Hospital, Monash University, Australia
  • Devasmita Choudhury, MD, FASN, Salem VA Medical Center, University of Virginia,
    Virginia Tech Carilion School of Medicine, United States
  • Pedro Henrique Franca Gois, MD, PhD, FASN, The University of Queensland, Australia
  • Rakhi Khanna, DO, FASN, Nephrology Associates of Northern Illinois and Indiana, United States
  • Eleanor D. Lederer, MD, FASN, UT Southwestern Medical Center, United States
  • Hugo Y.-H. Lin, MD, PhD, FASN, Kaohsiung Municipal Ta-Tung Hospital, Taiwan
  • Saugar Maripuri, MD, MPH, Hennepin County Medical Center, United States
  • Vidooshi G. Maru, MD, Nephrology Associates of Michigan, PC, United States
  • Kerri A. McGreal, MD, University of Kansas School of Medicine, United States
  • Ashraf I. Mikhail, MD, Morriston Hospital, United Kingdom
  • Dennis G. Moledina, MD, PhD, FASN, Yale School of Medicine, United States
  • Cynthia C. Nast, MD, FASN, Cedars-Sinai Medical Center, United States
  • Georges Ouellet, MD, Maisonneuve-Rosemont Hospital, Canada
  • Pairach Pintavorn, MD, FASN, East Georgia Kidney Group, United States
  • Anastasia Ptinopoulou, MD, PhD, General Hospital of Trikala , Greece
  • Jean-Sebastien Rachoin, MD, FASN, United States
  • Karthik Ramani, MD, MBBS, FASN, University of Michigan United States
  • Hernan Rincon-Choles, MD, MS, FASN, Cleveland Clinic United States
  • Jorge Enrique Rojas-Rivera, MD, Hospital Universitario Fundación Jiménez Díaz, Spain
  • Hitesh H. Shah, MD, FASN, Zucker School of Medicine at Hofstra/Northwell, United States
  • Mukesh K. Sharma, MD, MS, FASN, Sierra Nevada Nephrology Consultants, United States
  • Mwf van den Hoogen, MD, PhD, Erasmus MC Medical Centre Rotterdam, Netherlands
  • Julie M. Yabu, MD, MS, FASN, David Geffen School of Medicine at UCLA, United States
  • Michifumi Yamashita, MD, PhD, FASN, Cedars-Sinai Medical Center, United States
  • Brian Y. Young, MD, FASN, UC Davis Medical Center, United States

 

Program Mission and Objectives

nephSAP® provides a learning vehicle for physicians, scientists, advanced practitioners, nurses, pharmacists, and other health professionals working and training in the field of nephrology to renew and refresh their clinical knowledge, diagnostic, and therapeutic skills. This enduring material provides learners challenging, clinically-oriented questions based on case vignettes, detailed learning objectives, a series of articles that review recent publications, and an editorial on an important and evolving topic. This combination of materials enables learners to rigorously assess their strengths and weaknesses in the broad domain of nephrology.

Target Audience

Physicians, scientists, advanced practitioners, nurses, pharmacists, and other health professionals working and training in the field of nephrology.

Accreditation and AMA Credit Designation Statements

Jointly Accredited Provider LogoIn support of improving patient care, the American Society of Nephrology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The American Society of Nephrology designates this internet activity (enduring material) for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to Joint Accreditation for the purpose of granting ABIM MOC credit. MOC points will be applied to only those ABIM candidates who have enrolled in the MOC program. It is your responsibility to complete the ABIM MOC enrollment process.

Original Release Date: August 2022

CME/MOC Termination Date: July 31, 2024

Examination Available Online: On or before August 31, 2022

Estimated Time for Completion: 10 hours 

Self-Assessment Examination

  • Answers with explanations are provided with a passing score after the first and/or second attempt
  • This issue will be archived August 1, 2024, and answers with explanations will be posted on the ASN website

Method of Participation

  • Read the entire issue that is supplemented by original articles in the reference lists.
  • Complete the online self-assessment examination.
  • Each participant is allowed two attempts to pass the examination (75% correct) for CME and MOC.
  • Upon completion, review your score and incorrect answers and print your certificate.

Activity Evaluation, CME and MOC

  • Go to ASN eLEARNING CENTER (education.asn-online.org)
  • Select MY ACTIVITIES from the left-hand navigation.
  • Select the corresponding issue.
  • Read all information on the Overview screen.
  • Follow the onscreen instructions to:
    • Complete the Exam (i.e., post test),
    • Complete the Evaluation,
    • Claim credit/MOC, and
    • Print a Certificate

Your ASN Transcript is available on the ASN website:

  • Go to the ASN website and log in to your ASN Profile page
  • Select the CME/CE Transcript tab
  • View credits claimed or print a certificate with continuing education information for completed learning activities

 

Instructions to obtain American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) Points

Each issue of nephSAP provides 10 MOC points. Respondents must meet the following criteria:

  • Be certified by ABIM in internal medicine and/or nephrology and enrolled in the ABIM–MOC program...
  • Enroll for MOC via the ABIM website (www.abim.org).
  • Enter your (ABIM) Candidate Number and Date of Birth prior to completing the examination.
  • Take the self-assessment examination within the timeframe specified in this issue of nephSAP.
  • Upon completion, click Claim Your MOC points, the MOC points submitted will match your CME credits claimed, check the Attestation Statement box and submit.
  • ABIM will notify you when MOC points have been added to your record.

ABIM MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to Joint Accreditation for the purpose of granting ABIM MOC credit.
 
MOC points will be applied to only those ABIM candidates who have enrolled in the MOC program. It is your responsibility to complete the ABIM MOC enrollment process.
 

System Requirements Compatible Browser and Software

The nephSAP website (nephsap.org) is formatted for cross-browser functionality, and should display correctly in all currently supported web browsers. Individual nephSAP articles are available as dynamic HTML or in Portable Document Format (PDF), which requires Adobe Reader or comparable PDF viewing software.
 

Monitor Settings

The nephSAP website is designed for responsive display. This means the content display will respond to the device you use and to your devices screen resolution.  
 

Medium or Combination of Media Used

The media used include content provided online as dynamic HTML or downloadable PDF, in addition to an online evaluation and self-assessment examination.
 

Technical Support

If you have difficulty viewing any of the pages, please refer to the nephSAP technical support page for possible solutions. If you continue having problems, contact ASN at nephsap@asn-online.org.
 

 

  • Collapse
  • Expand

Volume 21: Issue 3 (Aug 2022): Transplantation

in Nephrology Self-Assessment Program